Abstract
Introduction Oral language skills are associated with children’s later self-regulation and academic skills; in turn, self-regulation in early childhood predicts successful functioning later in life. The primary objective of this study is to evaluate the separate and combined effectiveness of an oral language intervention (ENRICH) and a self-regulation intervention (ENGAGE) with early childhood teachers and parents for children’s oral language, self-regulation, and academic functioning.
Methods and Analysis The Best Start study (Kia Tīmata Pai in te reo Māori, the indigenous language of New Zealand) is a cluster randomized controlled trial with teachers and children in approximately 140 early childhood centres in New Zealand. Centres are randomly assigned to receive either oral language intervention only (ENRICH), self-regulation intervention only (ENGAGE), both interventions (ENRICH + ENGAGE), or an active control condition. Teachers’ and parents’ practices and children’s oral language and self-regulation development are assessed at baseline at age 1.5 years and every 9-months to age 5, and academic performance at age 6. Teacher-child interactions will also be videotaped each year in a subset of the centres. Children’s brain and behavior development and parent-child interactions will be assessed every 6 months to age 6 years in a sub-group of volunteers.
Ethics and Dissemination The Best Start trial and the two sub-studies (Video Project; Brain and Behavior Development) have been approved by the University of Otago Health Ethics Committee (H20/116), and reviewed for cultural responsiveness by: the Ngāi Tahu Research Committee (University of Otago), the Māori Advisory Group (University of Auckland, Liggins Institute) and an internal cultural advisory group. Results will be disseminated in international and national peer-reviewed academic journals and communicated to local, national, and international organizations serving early childhood teachers, parents, and young children.
Trial registration This trial is registered with the Australian New Zealand Clinical Trial Registry (ANZCTR) as ACTRN12621000845831.
Strengths and Limitations of This Study
Strength: The size and longitudinal design of this cluster RCT across early childhood will enable the assessment of the singular and combined effects of teacher-led oral language and self-regulation interventions on the development of children’s oral language, self-regulation, and academic functioning.
Strength: The trial represents a partnership between a large provider of early childhood education (BestStart), an external implementation service (Methodist Mission Southern), and a consortium of academics (Emotion Regulation Aoetaroa/New Zealand) to provide a culturally responsive intervention with co-designed implementation with the early childhood education provider (BestStart); the use of a single national provider simplifies co-design and the implementation of the intervention.
Strength: The efficacy of the interventions is assessed at multiple levels: via teacher and parent reports, behavioral observations, and measures of brain development (EEG/ERP).
Limitation: Because of the large size of the main trial, those assessments are restricted to teacher- and parent-report instruments.
Limitation: The single-provider feature with BestStart restricts the ability to collect primary outcomes on children who leave this service provider during early childhood.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ACTRN12621000845831
Clinical Protocols
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381848&isClinicalTrial=False
Funding Statement
This research is funded by a Wright Family Foundation Grant to RP. https://www.wrightfamilyfoundation.org.nz/ Wellcome Leap Inc. (Project Number 3724974-S001) also provided seed funding for the Brain Development and Behavior sub-study. https://wellcomeleap.org/1kd/ The funders play no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Health Ethics Committee of the University of Otago gave ethical approval for this work (H20/116).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: Funding for the Best Start trial and for the Brain Development and Behavior sub-study was obtained from the Wright Family Foundation. The Wellcome Leap provided funding for the equipment, materials, and staff for the baseline phase of the Brain Development and Behavior sub-study. The design, management, analysis, and reporting of the study are independent of the Wright Family Foundation and Wellcome Leap. The principal investigators (Richie Poulton and Elaine Reese) and co-investigators (Jesse Kokaua, Hayley Guiney, Tugce Bakir-Demir, Elizabeth Schaughency, Karen Salmon, Mele Taumoepeau, Amanda Clifford, Peter Gluckman, and Justin O’Sullivan) report no financial or other competing interests.
Sponsor: Emotion Regulation Aotearoa New Zealand (ERANZ) is the sponsor for this trial. Members of ERANZ include RP, ER, SM, ES, MT, KS, and PG.
The sponsor is responsible for the study design of the main trial; collection, management, analysis, and interpretation of the data; and the decision to submit reports for publication.
Strengths and limitations section added; additional details provided throughout Methods and Analysis section, including more information about the two interventions (ENRICH and ENGAGE; see Tables 1 and 2); Figure 2 updated; author added.
Data Availability
No datasets were generated or analysed during the current study protocol.
